The response observed in women with EOC lacking BRCA1/2 mutations was attributed to ‘BRCA-ness’, a molecular genetic signature in cancers equivalent to those with a BRCA1/2 mutation [15] where other HR components were deficient by mutation or were epigenetically silenced [16, 17]. Here, BRCA1 is linked to cancer.